FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3891486014 | Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3891487017 | Conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 1202715012 | Estrogens, conjugated + estrogens, esterified + medroxyprogesterone acetate 0.625mg/0.625mg/5mg tablet (product) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 1202715012 | Estrogens, conjugated + estrogens, esterified + medroxyprogesterone acetate 0.625mg/0.625mg/5mg tablet (product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 1215596012 | Estrogens, conjugated + estrogens, esterified + medroxyprogesterone acetate 0.625mg/0.625mg/5mg tablet | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 1478756013 | Estrogens, conjugated+estrogens, esterified+medroxyprogesterone acetate 0.625mg/0.625mg/5mg tablet | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 1478756013 | Estrogens, conjugated+estrogens, esterified+medroxyprogesterone acetate 0.625mg/0.625mg/5mg tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3763473016 | Product containing precisely conjugated estrogens 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3763474010 | Conjugated estrogens 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3891486014 | Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3891487017 | Conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing medroxyprogesterone acetate | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing medroxyprogesterone in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Medroxyprogesterone acetate | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | estrogeno | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Estrogenic preparation (substance) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Progesterone | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Conventional release oral tablet (dose form) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing medroxyprogesterone in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing medroxyprogesterone acetate in oral dosage form | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Medroxyprogesterone (substance) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
| Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
| Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | estrogènes conjuguès | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
| Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 3 | |
| Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | estrogènes conjuguès | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
| Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit (attribute) | mcg | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
| Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
| Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 625 | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
| Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | trois | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
| Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 3 | |
| Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing only conjugated estrogen and esterified estrogen and medroxyprogesterone in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Esterified estrogen (substance) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
| Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | cinq | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 3 | |
| Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit (attribute) | mg | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 3 | |
| Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Esterified estrogen (substance) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
| Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Medroxyprogesterone acetate | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 3 | |
| Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit (attribute) | mcg | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
| Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 625 | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
| Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Medroxyprogesterone acetate | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 3 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets